MoonLake Immunotherapeutics
MLTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821586
In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 5 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in MoonLake Immunotherapeutics as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 136
- +21 vs. Q4 2024
- Shares held
- 59.9M
- −2.93M (−4.7%) vs. Q4 2024
- Total value
- $2.34B
- −$1.06B (−31.2%) vs. Q4 2024
- New holders
- 37
- 32 more added
- Sold out
- 16
- 43 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MLTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 172 | $1.43B |
| Q1 2026 | 147 | $1.17B |
| Q4 2025 | 130 | $742.9M |
| Q3 2025 | 134 | $269.7M |
| Q2 2025 | 130 | $2.77B |
| Q1 2025 | 136 | $2.34B |
| Q4 2024 | 116 | $3.43B |
| Q3 2024 | 109 | $3.14B |
| Q2 2024 | 111 | $2.67B |
| Q1 2024 | 114 | $2.99B |
| Q4 2023 | 125 | $3.53B |
| Q3 2023 | 118 | $3.21B |
| Q2 2023 | 83 | $2.86B |
| Q1 2023 | 43 | $843.2M |
| Q4 2022 | 33 | $396.4M |
| Q3 2022 | 24 | $291.4M |
| Q2 2022 | 23 | $190.1M |
| Q1 2022 | 27 | $123.4M |
| Q4 2021 | 45 | $112.8M |
| Q3 2021 | 43 | $111.1M |
| Q2 2021 | 46 | $115.8M |
| Q1 2021 | 42 | $108.9M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding MoonLake Immunotherapeutics; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| LPL Financial LLC | 8,847 | $345.7K | 0.00% | +701+8.6% | Added |
| XTX Topco Ltd | 8,495 | $331.9K | 0.02% | +8,495 | New |
| Birchview Capital, LP | 8,000 | $312.6K | 0.27% | +4,000+100.0% | Added |
| New York State Common Retirement Fund | 6,992 | $273.2K | 0.00% | +6,992 | New |
| Glenmede Trust Co NA | 6,690 | $261.4K | 0.00% | +6,690 | New |
| Arizona State Retirement System | 6,332 | $247.4K | 0.00% | −39−0.6% | Reduced |
| BNP Paribas Arbitrage, SA | 6,328 | $247.2K | 0.00% | −1,305−17.1% | Reduced |
| Legato Capital Management LLC | 6,142 | $240.0K | 0.03% | +6,142 | New |
| Teacher Retirement System of Texas | 5,940 | $232.1K | 0.00% | −592−9.1% | Reduced |
| Russell Investments Group, Ltd. | 5,460 | $213.3K | 0.00% | −50,430−90.2% | Reduced |
| ADAR1 Capital Management, LLC | 5,424 | $211.9K | 0.04% | −12,000−68.9% | Reduced |
| KLP Kapitalforvaltning AS | 4,500 | $175.8K | 0.00% | 00.0% | Unchanged |
| Advisors Asset Management, Inc. | 4,009 | $156.6K | 0.00% | +1,803+81.7% | Added |
| Virtus Investment Advisers, Inc. | 3,050 | $119.2K | 0.03% | +3,050 | New |
| Bellevue Group AG | 3,000 | $117.2K | 0.00% | −1,400−31.8% | Reduced |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2,753 | $107.6K | 0.00% | 00.0% | Unchanged |
| Quarry LP | 2,400 | $93.8K | 0.02% | +2,400 | New |
| US Bancorp | 2,208 | $86.3K | 0.00% | +1,178+114.4% | Added |
| Deutsche Bank AG | 903 | $35.3K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 841 | $32.9K | 0.00% | −409−32.7% | Reduced |
| Wells Fargo & Company | 725 | $28.3K | 0.00% | +400+123.1% | Added |
| Private Trust Co NA | 193 | $7.54K | 0.00% | 00.0% | Unchanged |
| Caitong International Asset Management Co., Ltd | 147 | $5.74K | 0.00% | +147 | New |
| Tower Research Capital LLC (TRC) | 146 | $5.70K | 0.00% | +146 | New |
| Wealth Preservation Advisors, LLC | 120 | $4.69K | 0.00% | +120 | New |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | 85 | $3.32K | 0.00% | 00.0% | Unchanged |
| Aquatic Capital Management LLC | 82 | $3.20K | 0.00% | +82 | New |
| Advisor Group Holdings, Inc. | 75 | $2.93K | 0.00% | 00.0% | Unchanged |
| Geneos Wealth Management Inc. | 6 | $2.07K | 0.00% | −8−57.1% | Reduced |
| CWM, LLC | 49 | $2.00K | 0.00% | +24+96.0% | Added |
| J.Safra Asset Management Corp | 51 | $1.99K | 0.00% | +43+537.5% | Added |
| Amundi | 12 | $457 | 0.00% | 00.0% | Unchanged |
| Creative Financial Designs Inc | 10 | $391 | 0.00% | +10 | New |
| TD Private Client Wealth LLC | 9 | $352 | 0.00% | +9 | New |
| True Wealth Design, LLC | 4 | $157 | 0.00% | +4 | New |
| Lindbrook Capital, LLC | 4 | $156 | 0.00% | +4 | New |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −332,522−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −155,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −98,719−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −54,294−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −20,740−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −12,371−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −10,576−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −9,229−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −5,028−100.0% | Sold out |
| PEAK6 LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −3,208−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −1,322−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −78−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | 0 | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |